Filing Details
- Accession Number:
- 0001209191-21-041176
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-16 20:21:29
- Reporting Period:
- 2021-06-14
- Accepted Time:
- 2021-06-16 20:21:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1599901 | Avidity Biosciences Inc. | RNA | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1181556 | A Arthur Levin | C/O Avidity Biosciences, Inc. 10975 N. Torrey Pines Rd., Suite 150 La Jolla CA 92037 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-06-14 | 14,003 | $25.92 | 23,019 | No | 4 | S | Indirect | By charitable remainder trust |
| Common Stock | Disposition | 2021-06-15 | 23,019 | $26.02 | 0 | No | 4 | S | Indirect | By charitable remainder trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By charitable remainder trust |
| No | 4 | S | Indirect | By charitable remainder trust |
Footnotes
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $25.70 to $26.06. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $25.62 to $26.47. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
